You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

High grade serous

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

High Grade Serous Adenocarcinoma of Ovary, Fallopian Tube Cancer, Primary Peritoneal Carcinoma Trial (Sovilnesib)

Not yet recruiting
  • High Grade Serous Adenocarcinoma of Ovary
  • +3 more
  • (no location specified)
Oct 13, 2023

High Grade Serous Ovarian Cancer (HGSOC) Trial (FAPI PET CT)

Not yet recruiting
  • High Grade Serous Ovarian Cancer (HGSOC)
  • FAPI PET CT
  • (no location specified)
Jul 20, 2023

Ovarian Cancer, Relapsed Ovarian Cancer, Fallopian Tube Cancer Trial (Carboplatin)

Not yet recruiting
  • Ovarian Cancer
  • +6 more
  • (no location specified)
Oct 27, 2022

New Prognostic Index for Neoadjuvant Chemotherapy Outcome in

Enrolling by invitation
  • Ovarian Cancer
  • +2 more
  • CRS scoring
  • Routine blood laboratory testing before treatment
  • Guangzhou, Guangdong, China
    The Sun Yat-sen Memorial Hospital of Sun Yat-sen University
Nov 2, 2023

High Grade Fallopian Tube Serous Adenocarcinoma, High Grade Ovarian Serous Adenocarcinoma, Peritoneal High Grade Serous

Recruiting
  • High Grade Fallopian Tube Serous Adenocarcinoma
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 9, 2022

Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma, Ovarian Endometrioid Adenocarcinoma

Recruiting
  • Fallopian Tube Endometrioid Adenocarcinoma
  • +17 more
  • Biopsy
  • +3 more
  • Augusta, Georgia
  • +4 more
Jan 25, 2023

Tumor, Ovarian, Fallopian Tube Cancer, Primary Peritoneal Cavity Cancer Trial (AVB-001 (Dose Escalation Phase), AVB-001 (Dose

Not yet recruiting
  • Neoplasm, Ovarian
  • +7 more
  • AVB-001 (Dose Escalation Phase)
  • AVB-001 (Dose Expansion Phase)
  • (no location specified)
Sep 15, 2022

Fallopian Tube Carcinosarcoma, Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma Trial in

Recruiting
  • Fallopian Tube Carcinosarcoma
  • +28 more
  • Pegylated Liposomal Doxorubicin Hydrochloride
  • Peposertib
  • Aurora, Colorado
  • +7 more
Sep 2, 2022

Investigate Adaptation and Evolution of Ovarian High-grade

Recruiting
  • Ovarian Cancer
  • +6 more
    • Bristol, United Kingdom
    • +10 more
    Sep 8, 2022

    Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma Trial in Philadelphia (MOv19-BBz CAR T cells, Alpha Folate

    Recruiting
    • Ovarian Cancer
    • +2 more
    • MOv19-BBz CAR T cells
    • Alpha Folate Receptor expression test
    • Philadelphia, Pennsylvania
      University of Pennsylvania Health System
    Sep 12, 2022

    Pembrolizumab and Anlotinib in Treatment of High-Grade Serous

    Completed
    • High-Grade Serous Ovarian Cancer
    • Pembrolizumab combined Anlotinib
    • Qingdao, Shandong, China
      Xiaochun Zhang
    Dec 26, 2021

    miRNAs in High Grade Serous Ovarian Cancer

    Recruiting
    • High Grade Serous Ovarian Cancer
      • Bologna, Bo, Italy
        IRCCS- Azienda Ospedaliera-Universitaria di Bologna
      Dec 3, 2021

      Ovarian Cancer, High Grade Ovarian Serous Trial in New York (PET/MRI, Contrast enhanced CT)

      Active, not recruiting
      • Ovarian Cancer
      • High Grade Ovarian Serous
      • PET/MRI
      • Contrast enhanced CT
      • New York, New York
        Memorial Sloan Kettering Cancer Center (All Protocol Activities)
      Mar 2, 2022

      Fallopian Tube Carcinosarcoma, Primary Peritoneal Carcinosarcoma, Recurrent Fallopian Tube Carcinoma Trial in Rochester (Biopsy,

      Not yet recruiting
      • Fallopian Tube Carcinosarcoma
      • +14 more
      • Biopsy
      • +6 more
      • Rochester, Minnesota
        Mayo Clinic in Rochester
      Jun 28, 2023

      Ovarian Cancer Trial in Kelowna, Vancouver, Kingston (Durvalumab, BA3011, BA3021)

      Recruiting
      • Ovarian Cancer
      • Kelowna, British Columbia, Canada
      • +4 more
      Nov 14, 2022

      High Grade Serous Ovarian Cancer Trial in Montpellier (Blood sample and tissue sample)

      Not yet recruiting
      • High Grade Serous Ovarian Cancer
      • Blood sample and tissue sample
      • Montpellier, France
        NOUGARET Stephanie
      Oct 10, 2023

      Ovarian Cancer, High Grade Serous Adenocarcinoma of Ovary, High Grade Endometrioid Ovarian Cancer Trial in Guangzhou (Fluzoparib

      Not yet recruiting
      • Ovarian Cancer
      • +4 more
      • Guangzhou, Guangdong, China
        Sun Yat-sen University Cancer Cetntre
      Sep 25, 2023

      Platinum-resistant Ovarian Cancer Trial in China (IN10018 in combination with PLD)

      Recruiting
      • Platinum-resistant Ovarian Cancer
      • IN10018 in combination with PLD
      • Anyang, China
      • +6 more
      Sep 20, 2022

      Chromosomal Instability in Ovarian Cancer

      Recruiting
      • Epithelial Ovarian Cancer
      • +7 more
      • Testing for chromosomal instability (CIN)
      • Beijing, Beijing, China
        Lei Li
      Mar 26, 2022

      High Grade Serous Carcinoma, Triple Negative Breast Cancer, Ovarian Cancer Trial (Olaparib tablet, Navitoclax)

      Recruiting
      • High Grade Serous Carcinoma
      • +2 more
      • Toronto, Ontario, Canada
      • +2 more
      Nov 28, 2022

      Early Detection of High Grade Serous Epithelial Ovarian Cancer

      Active, not recruiting
      • Epithelial Ovarian Cancer
      • DNA Methylation
      • Dallas, Texas
        Baylor University Medical Center
      Jan 31, 2022

      CINSARC Genomic Signature as Predictor of Resectability of

      Completed
      • Ovarian Adenocarcinoma
      • CINSARC signature
      • Toulouse, France
        Institut Claudius Regaud Institut Universitaire du cancer Toulou
      Dec 22, 2022

      High-grade Serous Ovarian Cancer Trial in Belgium, Spain, United Kingdom (APR-246, Pegylated Liposomal Doxorubicin Hydrochloride

      Completed
      Has Results
      • High-grade Serous Ovarian Cancer
      • APR-246
      • Pegylated Liposomal Doxorubicin Hydrochloride (PLD)
      • Gent, Belgium
      • +11 more
      Jul 19, 2022

      Hyperthermic Intraperitoneal Chemo, Neoadjuvant Chemo Trial in Guangzhou (HIPEC, intravenous chemo)

      Recruiting
      • Hyperthermic Intraperitoneal Chemotherapy
      • Neoadjuvant Chemotherapy
      • HIPEC
      • intravenous chemotherapy
      • Guangzhou, Other (Non U.s.), China
        Sun Yat-sen Memorial Hospital
      Feb 17, 2022

      High Grade Serous Ovarian, Fallopian Tube, Primary Peritoneal Cancer Trial in New York (Carboplatin and Paclitaxel, Nivolumab,

      Active, not recruiting
      • High Grade Serous Ovarian
      • +2 more
      • Carboplatin and Paclitaxel
      • +3 more
      • New York, New York
        Memorial Sloan Kettering Cancer Center
      Apr 13, 2022